Delivery Order 36F79720D0189-36C26124N0408
Award Date
1/26/24
Potential Completion Date
3/26/24
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 21
Awardee
Incyte Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Talleyville, DE 19803, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Incyte Corporation was awarded a $12,725.23 delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to supply 13.5mg Pemigatinib tablets. The order was issued against Incyte's Pharmaceuticals and Drugs Federal Supply Schedule contract to fulfill a request for the specialized cancer medication. With no set aside designation applied, Incyte will deliver the Pemigatinib tablets as the prime contractor under a firm fixed price...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration Veterans Integrated Service Network 21 to Incyte Corporation, a global biopharmaceutical company. The $13,290.97 delivery order contract is for the drug Pemigatinib, which is used to treat certain types of cancer. The contract was awarded under Incyte's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA, and has a firm fixed price. No set-aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725 delivery order contract to Incyte Corporation. Under the terms of the contract, Incyte will provide Pemigatinib to the VA network through January 2024. The contract was awarded against Incyte's Pharmaceuticals and Drugs schedule (FSS-61-IB) master agreement with the General Services Administration. Pemigatinib will be delivered to the VA network's location in Talleyville,...
Incyte Corporation was awarded a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12. The delivery order, which has no set aside designation and completion date of October 30, 2020, is for the provision of PEMAZYRE to treat patients. The firm fixed price order was awarded on October 5, 2020 under Incyte's master GSA Schedule contract vehicle. The place...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,725 delivery order against Incyte Corporation's Pharmaceuticals and Drugs GSA Schedule contract number FSS-61-IB. This firm fixed price order is to provide PEMIGATINIB/PEMAZYRE 4.5MG tablets for use in VA's healthcare programs from November 3rd to December 4th, 2023. Place of performance will be Incyte's facility in Talleyville, Delaware. No subcontractors or set aside...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $12,873.68 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Incyte Corporation. The firm fixed price order is for the provision of PEMIGATINIB (PEMAZYRE) 4.5MG tablets to the VA medical center located in Talleyville, Delaware, with performance taking place from July 28, 2023 through September 28, 2023. As the prime contractor, Incyte will...
The Department of Veterans Affairs Veterans Health Administration awarded Incyte Corporation a $556.97 million firm fixed price delivery order against their Pharmaceuticals and Drugs GSA Schedule contract. This order is to provide PEMAZYRE 9MG tablets to VHA facilities in Veterans Integrated Service Network 15. The place of performance is Incyte's location in Talleyville, Delaware and the period of performance runs from November 2020 through November 2021. No set aside designation or...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded Incyte Corporation a $12,725.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for a firm fixed price. The order is for PEMAZYRE 9 MG tablets to fulfill requirements under the referenced master agreement. Performance will take place in San Diego, California with completion by July 28, 2021. No set-aside provisions were applied to this...
Incyte Corporation has been awarded a $12,811.62 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The firm fixed price order is for PEMIGATINIB/PEMAZYRE 9MG TAB to be delivered to a location in Fresno, California by May 22, 2023. No set-aside designation was applied to this order placed under GSA Schedule FSS-61-IB to supply pharmaceutical products and drugs in...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $12,725.23 delivery order to Incyte Corporation under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB). The firm fixed price order is for PEMAZYRE 9 MG tablets to fulfill requirements through September 30th, 2022. Place of performance will be Incyte Corporation's location in West Chester Township, Ohio. No set-aside designation was applied to this order to...